Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $59.05 Analyst target: $50.50 Upside: -14.48%
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases globally. The company is headquartered in Mountain View, California.
See the full interactive analysis & chart →Informational only — not investment advice.